FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4823211000001100: Agenerase 15mg/ml oral solution (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18511301000001119 Agenerase 15mg/ml oral solution (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58160501000001117 Agenerase 15mg/ml oral solution (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Is a Product containing precisely amprenavir 15 milligram/1 milliliter conventional release oral solution true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has active ingredient Amprenavir false Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has manufactured dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Is a Agenerase true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has specific active ingredient Amprenavir true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Agenerase 15mg/ml oral solution (GlaxoSmithKline) 240 ml Is pack of False Agenerase 15mg/ml oral solution (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Agenerase 15mg/ml oral solution (GlaxoSmithKline) 240 ml Has AMP True Agenerase 15mg/ml oral solution (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start